Aarhus University Seal / Aarhus Universitets segl

Peter Vedsted

Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Evidence of advanced stage colorectal cancer with longer diagnostic intervals : a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries. / Tørring, Marie Louise; Murchie, P; Hamilton, Willie; Vedsted, Peter; Esteva, M; Lautrup, Marianne Djernes; Winget, M; Rubin, Greg.

I: B J C, Bind 117, 09.2017, s. 888-897.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Tørring, Marie Louise ; Murchie, P ; Hamilton, Willie ; Vedsted, Peter ; Esteva, M ; Lautrup, Marianne Djernes ; Winget, M ; Rubin, Greg. / Evidence of advanced stage colorectal cancer with longer diagnostic intervals : a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries. I: B J C. 2017 ; Bind 117. s. 888-897.

Bibtex

@article{4b6f567033a84648896127c99a03df86,
title = "Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries",
abstract = "BACKGROUND: The benefits from expedited diagnosis of symptomatic cancer are uncertain. We aimed to analyse the relationship between stage of colorectal cancer (CRC) and the primary and specialist care components of the diagnostic interval.METHODS: We identified seven independent data sets from population-based studies in Scotland, England, Canada, Denmark and Spain during 1997-2010 with a total of 11 720 newly diagnosed CRC patients, who had initially presented with symptoms to a primary care physician. Data were extracted from patient records, registries, audits and questionnaires, respectively. Data sets were required to hold information on dates in the diagnostic interval (defined as the time from the first presentation of symptoms in primary care until the date of diagnosis), symptoms at first presentation in primary care, route of referral, gender, age and histologically confirmed stage. We carried out reanalysis of all individual data sets and, using the same method, analysed a pooled individual patient data set.RESULTS: The association between intervals and stage was similar in the individual and combined data set. There was a statistically significant convex (∩-shaped) association between primary care interval and diagnosis of advanced (i.e., distant or regional) rather than localised CRC (P=0.004), with odds beginning to increase from the first day on and peaking at 90 days. For specialist care, we saw an opposite and statistically significant concave (∪-shaped) association, with a trough at 60 days, between the interval and diagnosis of advanced CRC (P<0.001).CONCLUSIONS: This study provides evidence that longer diagnostic intervals are associated with more advanced CRC. Furthermore, the study cannot define a specific 'safe' waiting time as the length of the primary care interval appears to have negative impact from day one.British Journal of Cancer advance online publication 8 August 2017; doi:10.1038/bjc.2017.236 www.bjcancer.com.",
keywords = "Journal Article",
author = "T{\o}rring, {Marie Louise} and P Murchie and Willie Hamilton and Peter Vedsted and M Esteva and Lautrup, {Marianne Djernes} and M Winget and Greg Rubin",
year = "2017",
month = sep,
doi = "10.1038/bjc.2017.236",
language = "English",
volume = "117",
pages = "888--897",
journal = "B J C",
issn = "0007-0920",
publisher = "Nature Publishing Group",

}

RIS

TY - JOUR

T1 - Evidence of advanced stage colorectal cancer with longer diagnostic intervals

T2 - a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries

AU - Tørring, Marie Louise

AU - Murchie, P

AU - Hamilton, Willie

AU - Vedsted, Peter

AU - Esteva, M

AU - Lautrup, Marianne Djernes

AU - Winget, M

AU - Rubin, Greg

PY - 2017/9

Y1 - 2017/9

N2 - BACKGROUND: The benefits from expedited diagnosis of symptomatic cancer are uncertain. We aimed to analyse the relationship between stage of colorectal cancer (CRC) and the primary and specialist care components of the diagnostic interval.METHODS: We identified seven independent data sets from population-based studies in Scotland, England, Canada, Denmark and Spain during 1997-2010 with a total of 11 720 newly diagnosed CRC patients, who had initially presented with symptoms to a primary care physician. Data were extracted from patient records, registries, audits and questionnaires, respectively. Data sets were required to hold information on dates in the diagnostic interval (defined as the time from the first presentation of symptoms in primary care until the date of diagnosis), symptoms at first presentation in primary care, route of referral, gender, age and histologically confirmed stage. We carried out reanalysis of all individual data sets and, using the same method, analysed a pooled individual patient data set.RESULTS: The association between intervals and stage was similar in the individual and combined data set. There was a statistically significant convex (∩-shaped) association between primary care interval and diagnosis of advanced (i.e., distant or regional) rather than localised CRC (P=0.004), with odds beginning to increase from the first day on and peaking at 90 days. For specialist care, we saw an opposite and statistically significant concave (∪-shaped) association, with a trough at 60 days, between the interval and diagnosis of advanced CRC (P<0.001).CONCLUSIONS: This study provides evidence that longer diagnostic intervals are associated with more advanced CRC. Furthermore, the study cannot define a specific 'safe' waiting time as the length of the primary care interval appears to have negative impact from day one.British Journal of Cancer advance online publication 8 August 2017; doi:10.1038/bjc.2017.236 www.bjcancer.com.

AB - BACKGROUND: The benefits from expedited diagnosis of symptomatic cancer are uncertain. We aimed to analyse the relationship between stage of colorectal cancer (CRC) and the primary and specialist care components of the diagnostic interval.METHODS: We identified seven independent data sets from population-based studies in Scotland, England, Canada, Denmark and Spain during 1997-2010 with a total of 11 720 newly diagnosed CRC patients, who had initially presented with symptoms to a primary care physician. Data were extracted from patient records, registries, audits and questionnaires, respectively. Data sets were required to hold information on dates in the diagnostic interval (defined as the time from the first presentation of symptoms in primary care until the date of diagnosis), symptoms at first presentation in primary care, route of referral, gender, age and histologically confirmed stage. We carried out reanalysis of all individual data sets and, using the same method, analysed a pooled individual patient data set.RESULTS: The association between intervals and stage was similar in the individual and combined data set. There was a statistically significant convex (∩-shaped) association between primary care interval and diagnosis of advanced (i.e., distant or regional) rather than localised CRC (P=0.004), with odds beginning to increase from the first day on and peaking at 90 days. For specialist care, we saw an opposite and statistically significant concave (∪-shaped) association, with a trough at 60 days, between the interval and diagnosis of advanced CRC (P<0.001).CONCLUSIONS: This study provides evidence that longer diagnostic intervals are associated with more advanced CRC. Furthermore, the study cannot define a specific 'safe' waiting time as the length of the primary care interval appears to have negative impact from day one.British Journal of Cancer advance online publication 8 August 2017; doi:10.1038/bjc.2017.236 www.bjcancer.com.

KW - Journal Article

U2 - 10.1038/bjc.2017.236

DO - 10.1038/bjc.2017.236

M3 - Journal article

C2 - 28787432

VL - 117

SP - 888

EP - 897

JO - B J C

JF - B J C

SN - 0007-0920

ER -